Delayed hormonal therapy in advanced prostatic cancer.
作者信息
Zungri E, Salvador J, Chéchile G, Diaz I, Martinez E
机构信息
Department of Urology, Puigvert Foundation, Barcelona, Spain.
出版信息
Prog Clin Biol Res. 1987;243B:441-7.
PMID:3659038
Abstract
摘要
相似文献
1
Delayed hormonal therapy in advanced prostatic cancer.
Prog Clin Biol Res. 1987;243B:441-7.
2
Hormonal treatment of advanced disease: some newer aspects.
Semin Oncol. 1994 Oct;21(5):672-87.
3
Hormonal therapy of prostate cancer: current concepts and future prospects.
Clin Ther. 1988;10(3):281-6.
4
The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
Prog Clin Biol Res. 1987;243B:449-53.
5
Hormonal management of advanced adenocarcinoma of the prostate.
Henry Ford Hosp Med J. 1989;37(1):16-8.
6
Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Cancer. 2006 Apr 15;106(8):1708-14. doi: 10.1002/cncr.21799.
7
Deferred hormone treatment in prostate cancer.
Prog Clin Biol Res. 1987;243B:439-40.
8
Secondary hormonal therapy.
Semin Urol Oncol. 1997 Feb;15(1):3-12.
9
[Advanced prostatic carcinoma--which hormone therapy when?].
Urologe A. 1995 Sep;34(5):361-6.
10
Complete androgen blockade for the treatment of prostate cancer.
Important Adv Oncol. 1985:193-217.
引用本文的文献
1
Changes in serum levels of prostatic acid phosphatase and prostate specific antigen after luteinizing hormone-releasing hormone analogue administration in patients with metastatic prostatic cancer in relation to glandular differentiation.
Int Urol Nephrol. 1995;27(6):769-74. doi: 10.1007/BF02552145.
Zotero 插件